RECRUITMENT OF SPECIFICITY PROTEIN 1 BY CPG HYPOMETHYLATION UPREGULATES NA+-K+-2CL- COTRANSPORTER 1 IN HYPERTENSIVE RATS
Hyun-Min Cho and Inkyeom Kim
Department of Pharmacology, Cardiovascular Research Institute, Kyungpook National University School of Medicine, Daegu, 700-422, Republic of Korea
Abstract:
Objectives: Promoter hypomethylation leads to upregulation of Na+-K+-2Cl- cotransporter 1 (NKCC1) in the spontaneously hypertensive rat (SHR). We hypothesized that recruitment of Specificity Protein 1 (Sp1) by CpG hypomethylation would result in upregulation of Na+-K+-2Cl- cotransporter 1 in hypertensive rats.
Design and methods: Sham-operated WKY rats (sham) and angiotensin II (Ang II)-infused WKY rats, as well as SHRs, were used in this study. We performed real-time PCR and western blot for determination of the expression levels of Nkcc1 mRNA and protein, respectively, and bisulfite sequencing for determination of the methylation status of the proximal promoter; an assay kit was used for assessment of the activity of DNA methyltransferase (DNMT), and the electrophoretic mobility shift assay (EMSA) was used for assessment of binding of Sp1 to cis-element, and promoter function was assessed using the luciferase assay.
Results: Both Ang II-infused WKY rats and SHRs showed higher expression of Nkcc1 mRNA and protein and less DNA methylation, compared with sham. CpG methylation at Sp1 response elements interfered with binding of Sp1, resulting in disabled promoter activity. Both types of hypertensive rats showed hypomethylation of CpG dinucleotides in Sp1 response elements in accordance with the decrease of DNMT activity. DNMT3b and MeCP2 were highly recruited to the more methylated promoter of normotensive rats, whereas the CXXC finger protein 1, Sp1, and RNA polymerase II were highly recruited to the less methylated promoter of hypertensive rats.
Conclusions: Our results indicate that recruitment of Sp1 by CpG hypomethylation leads to upregulation of Na+-K+-2Cl- cotransporter 1 in hypertensive rats.
Keywords: NKCC1, Hypertension, DNA methylation, Sp1, DNMT activity, Epigenetic, Angiotensin II.